THE CLINICAL SIGNIFICANCE OF USING THE DN4 AND LANSS SCALES FOR THE DIAGNOSIS OF PAIN SYNDROME IN DIABETIC NEUROPATHY
Keywords:
diabetic neuropathy, neuropathic pain, DN4Abstract
Diabetic neuropathy is one of the most common and disabling complications of diabetes mellitus, occurring in 50-90% of patients, depending on the duration of the disease and the degree of compensation of carbohydrate metabolism. According to the International Diabetes Federation, by 2045 the number of diabetic patients in the world will reach 700 million people, which makes the problem of diabetic complications one of the priorities of modern medicine.
References
1. Bouhassira D., Attal N., Alchaar H., et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) // Pain. – 2005. – Vol. 114(1-2). – P. 29-36.
2. Bennett M.I., Smith B.H., Torrance N., Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research // Journal of Pain. – 2005. – Vol. 6(3). – P. 149-158.
3. Tesfaye S., Boulton A.J., Dyck P.J., et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments // Diabetes Care. – 2010. – Vol. 33(10). – P. 2285-2293.
4. Freynhagen R., Baron R., Gockel U., Tölle T.R. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain // Current Medical Research and Opinion. – 2006. – Vol. 22(10). – P. 1911-1920.
5. Cruccu G., Sommer C., Anand P., et al. EFNS guidelines on neuropathic pain assessment: revised 2009 // European Journal of Neurology. – 2010. – Vol. 17(8). – P. 1010-1018.
